Eyeluminaries

Author: John Hovanesian, MD, FACS and Jim Mazzo

A podcast hosted by John A. Hovanesian, MD, and Jim Mazzo who explore the latest news and trends with newsmakers and visionaries in eye care.
Be a guest on this podcast

Language: en-us

Genres: Health & Fitness, Medicine

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Trailer:

Get all podcast data

Listen Now...

Live from SightLine 2026: Discussing the launch of Yuvezzi
Episode 42
Monday, 3 August, 2026

In this episode, live from SightLine 2026, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Ben Bergo and Carol Kearney of Tenpoint Therapeutics. They discuss the approval of Yuvezzi (carbachol 2.75% and brimonidine tartrate 0.1% ophthalmic solution) for presbyopia as well as what it takes to launch a new product in a competitive market. · The beginning of Yuvezzi. 2:11 · How do you differentiate yourself from other products in the market? 7:34 · The fear of retinal detachment. 10:55 · Advice for young entrepreneurs. 13:31 · The decision to use brimonidine tartrate. 16:37 We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.